Inhibition of aldosterone secretion by ouabain in dog adrenal cortical tissue.
D015065:17-Hydroxycorticosteroids / Q000378:metabolism; D000311:Adrenal Glands / Q000187:drug effects / Q000378:metabolism*; D000450:Aldosterone / Q000378:metabolism*; D000818:Animals; D003345:Corticosterone / Q000378:metabolism*; D003864:Depression, Chemical; D004077:Digoxin / Q000494:pharmacology; D004285:Dogs; D006854:Hydrocortisone / Q000378:metabolism*; D006947:Hyperkalemia / Q000503:physiopathology; D007016:Hypophysectomy; D066298:In Vitro Techniques; D000451:Mineralocorticoid Receptor Antagonists; D009318:Natriuresis; D009392:Nephrectomy; D009941:Organomercury Compounds / Q000494:pharmacology; D010042:Ouabain / Q000494:pharmacology*; D011188:Potassium / Q000378:metabolism; D011194:Potassium Isotopes
D015065:17-Hydroxycorticosteroids; D000451:Mineralocorticoid Receptor Antagonists; D009941:Organomercury Compounds; D011194:Potassium Isotopes; D000450:Aldosterone; D010042:Ouabain; D004077:Digoxin; D011188:Potassium; D003345:Corticosterone; D006854:Hydrocortisone